ADVANCED BIOMARKER ASSAYS
AND DIAGNOSTIC TESTING
THE HOME OF AI AND MULTI-OMICS
PRECISION DIAGNOSTICS AND
ADVANCED BIOMARKER ASSAYS
DEVELOPED BY WORLD-LEADING EXPERTS
GSL delivers cutting-edge biomarker assays and diagnostic solutions powered by AI and decades of scientific knowledge, accelerating clinical development and improving patient outcomes.
We combine high-throughput mass spectrometry with AI-driven analytics to transform complex omics data into actionable insights. From assay development to diagnostic testing, we enable faster, smarter decisions for pharma and biotech innovators.
Our services help our partners streamline clinical trials, reduce costs, and accelerate time-to-market for life-changing therapies.
OUR SERVICES
GSL delivers three core services: Diagnostics for advanced disease detection, CoreLabs for high-quality biomarker assays, and bespoke Method Development.
Powered by AI and multi-omics expertise, we turn complex data into actionable insights.
DIAGNOSTICS
DIAGNOSTICS
AI-powered, multi-omics diagnostic testing for early and accurate disease detection.
CORELABS
CORELABS
Our AI-driven mass spectrometry delivers highly accurate biomarker assays for proteins, lipids, and metabolites
METHOD DEVELOPMENT
METHOD DEVELOPMENT
We design and validate bespoke biomarker methods using AI-driven analytics and mass spectrometry to deliver fast, accurate, and compliant results.
SION
VI
To redefine diagnostic excellence through machine learning-powered biomarker discovery and precision medicine.
WORLD-RENOWNED EXPERTS DRIVING INNOVATION
Our team brings decades of scientific heritage and deep expertise in omics, biomarker assays, and diagnostics, trusted by leading pharma and academic partners worldwide.
